Lexicon Pharmaceuticals, Inc. (LXRX)

NASDAQ: LXRX · Real-Time Price · USD

1.650

+0.050 (3.12%)

At close: Oct 15, 2026, 4:00 PM EDT

1.640

-0.010 (-0.61%)

Pre-market: Oct 16, 2026, 4:00 AM EDT

Lexicon Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	734	418	267	373	360	587
Market Cap Growth	38.37%	56.54%	-28.50%	3.58%	-38.55%	21.91%
Enterprise Value	603	367	114	261	255	480
Last Close Price	1.65	1.15	0.74	1.53	1.91	3.94

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	25.17	25.17	25.17	25.17	25.17
PS Ratio	17.70	8.39	8.59	310.10	2593.28	1968.62
PB Ratio	4.21	3.89	1.83	4.01	3.08	5.16
P/TBV Ratio	5.65	6.63	2.63	7.69	4.97	8.50

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	14.54	7.37	3.68	216.72	1833.75	1610.51

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.34	0.58	0.73	1.14	0.47	0.02
Net Debt / Equity Ratio	-0.75	-0.32	-0.90	-0.69	-0.71	-0.74
Net Debt / EBITDA Ratio	2.43	0.70	0.68	0.37	0.83	0.97
Net Debt / FCF Ratio	2.02	0.50	0.73	0.39	0.92	0.96
Asset Turnover	0.17	0.21	0.12	0.01	0.00	0.00
Inventory Turnover	8.50	25.64	21.10	-	-	-
Quick Ratio	13.07	4.73	5.34	5.42	5.97	3.92
Current Ratio	13.37	4.88	5.44	5.60	6.08	4.02
Return on Equity (ROE)	-40.21%	-39.72%	-167.66%	-168.50%	-88.37%	-65.01%
Return on Assets (ROA)	-14.32%	-12.65%	-46.42%	-50.67%	-37.91%	-31.95%
Return on Capital Employed (ROCE)	-23.20%	-29.80%	-77.40%	-86.80%	-58.70%	-75.90%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-8.32%	-12.05%	-75.07%	-47.44%	-28.28%	-14.96%
FCF Yield	-8.85%	-16.24%	-67.36%	-43.49%	-25.02%	-15.04%
Buyback Yield / Dilution	-7.98%	-13.44%	-44.73%	-33.42%	-13.79%	-31.41%

SEC Filings: 10-K · 10-Q